IS4726A - Meðhöndlun á heilaskemmdum vegna áverka - Google Patents

Meðhöndlun á heilaskemmdum vegna áverka

Info

Publication number
IS4726A
IS4726A IS4726A IS4726A IS4726A IS 4726 A IS4726 A IS 4726A IS 4726 A IS4726 A IS 4726A IS 4726 A IS4726 A IS 4726A IS 4726 A IS4726 A IS 4726A
Authority
IS
Iceland
Prior art keywords
trauma
treatment
damage due
brain damage
brain
Prior art date
Application number
IS4726A
Other languages
English (en)
Icelandic (is)
Inventor
R. Pike Brian
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS4726A publication Critical patent/IS4726A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IS4726A 1995-11-06 1998-04-27 Meðhöndlun á heilaskemmdum vegna áverka IS4726A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK123295 1995-11-06
PCT/DK1996/000458 WO1997017074A1 (en) 1995-11-06 1996-11-05 Treatment of traumatic brain injury

Publications (1)

Publication Number Publication Date
IS4726A true IS4726A (is) 1998-04-27

Family

ID=8102484

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4726A IS4726A (is) 1995-11-06 1998-04-27 Meðhöndlun á heilaskemmdum vegna áverka

Country Status (18)

Country Link
EP (1) EP0866706A1 (de)
JP (1) JPH11514654A (de)
KR (1) KR19990067353A (de)
AU (1) AU706594B2 (de)
BG (1) BG63150B1 (de)
BR (1) BR9611396A (de)
CA (1) CA2234824A1 (de)
CZ (1) CZ287441B6 (de)
EA (1) EA000531B1 (de)
HU (1) HUP9901051A2 (de)
IS (1) IS4726A (de)
NO (1) NO982036L (de)
NZ (1) NZ321546A (de)
PL (1) PL326490A1 (de)
SK (1) SK58198A3 (de)
TR (1) TR199800801T2 (de)
WO (1) WO1997017074A1 (de)
ZA (1) ZA969320B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR013096A1 (es) * 1997-07-01 2000-12-13 Lundbeck & Co As H Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
IE922270A1 (en) * 1991-07-26 1993-01-27 Akzo Nv Pyrazole derivatives
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives

Also Published As

Publication number Publication date
CA2234824A1 (en) 1997-05-15
ZA969320B (en) 1997-05-30
JPH11514654A (ja) 1999-12-14
EA000531B1 (ru) 1999-10-28
PL326490A1 (en) 1998-09-28
BR9611396A (pt) 1999-07-13
EP0866706A1 (de) 1998-09-30
EA199800434A1 (ru) 1998-10-29
AU706594B2 (en) 1999-06-17
NZ321546A (en) 2000-12-22
CZ138998A3 (cs) 1998-10-14
HUP9901051A2 (hu) 2000-03-28
SK58198A3 (en) 1998-10-07
NO982036D0 (no) 1998-05-05
WO1997017074A1 (en) 1997-05-15
MX9803432A (es) 1998-09-30
TR199800801T2 (xx) 1998-08-21
NO982036L (no) 1998-06-25
CZ287441B6 (en) 2000-11-15
BG63150B1 (bg) 2001-05-31
AU7490096A (en) 1997-05-29
KR19990067353A (ko) 1999-08-16
BG102480A (en) 1999-01-29

Similar Documents

Publication Publication Date Title
FI964874A (fi) Vihannesten käsittely
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
DE69635311D1 (de) Elektrochirugische gewebeentfernung
DE69615105D1 (de) Enzymatische Behandlung von Kakao
DE69500089D1 (de) Behandlung von Geflügel
DE69622993D1 (de) Sanft behandeltes ungekrepptes durchblasgetrocknetes tissue
BR9600969A (pt) Método de tratamento de doença inflamatória cardíaca
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
AU8117591A (en) Treatment of water
NO963785D0 (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
FI956339A (fi) Hypotalaamisen kuukautisten puuttumisen hoitaminen
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
NO922214D0 (no) Fettsyrebehandling
DE69620359D1 (de) Chirurgischer Verband
BR9101494A (pt) Tratamento de tecidos
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
IS4726A (is) Meðhöndlun á heilaskemmdum vegna áverka
FI930182A0 (fi) Menetelmä elintarvikekäyttöön tarkoitetun teollisesti idätettävän siemenmateriaalin käsittelemiseksi
NO982582D0 (no) FremgangsmÕte for behandling av smerte
NO981866L (no) Terapeutisk anvendelse av hemoglobin for Õ fremme sÕrheling
NO982562D0 (no) Sammensetning for behandling av smerte
KR970038973U (ko) 수처리용 여과기
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
KR960025637U (ko) 간격조절이 용이한 콘넥터